Clinical Trial Update: Acute Hemodynamic Effect of Acetazolamide in Pulmonary Hypertension [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial investigating the acute hemodynamic effects of acetazolamide in pulmonary hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Drugs mentioned

• ACETAZOLAMIDE (acetazolamide)

Snippet

Sponsor: University of Zurich | Conditions: Hypertension, Pulmonary | Phase 2, Phase 3 | Status: COMPLETED